A promising new therapy against viruses was developed at University of Manitoba and Theralase Technologies. The study evaluated antiviral effectiveness of a cancer drug (Ruvidar), activated with Modulight’s ML6600 green laser.
Modulight Spotlights: LASER-SHARP RESEARCH – June 2024 Read More »
Dr. Makoto Mitsunaga et al. Jikei University School of Medicine published in Communications Biology journal about developing a next-generation light-based approach to tackle pathogens, called photoimmuno-antimicrobial strategy (PIAS). This technology was shown to eliminate a broad spectrum of different classes of pathogens, such as viruses, fungi, and bacteria.
Modulight Spotlights: LASER-SHARP RESEARCH – July 2022 Read More »
